AzTrials
AzTrials

Gait, UnsteadyNCT03605290

Comparison Between Two Operational Techniques for Total Knee Replacement

A study testing REHAGAIT ANYLIZER in people with Gait, Unsteady and Knee Arthropathy, run by HaEmek Medical Center, Israel at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Advance Knee osteoarthritis is treated by Total knee replacement. Since the first TKR in 1973 there has been continuous advance in implant technology as well as operative technique, yet current patient satisfaction after the procedure is accepted to be about 80%. There are a few operative techniques to perform TKR. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Gait, Unsteady, Knee Arthropathy, Surgery
What is being tested?
REHAGAIT ANYLIZER
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteIsrael
Study dates
15 Jun 2018to 1 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients after total knee replacement which was performed in our ward.

Who cannot join

  • Less than 6 months have passed after the procedure
  • Inability to understand and fill out PROMS questionnaires.
  • Inability to walk without aids for at least 20 meters.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • haemek MC

    Afula

Other trials in Israel

About this study

Official title: Comparison Between Two Operational Techniques for Total Knee Replacement: A Prospective, Case Control, Double Blinded Study

Advance Knee osteoarthritis is treated by Total knee replacement. Since the first TKR in 1973 there has been continuous advance in implant technology as well as operative technique, yet current patient satisfaction after the procedure is accepted to be about 80%.

There are a few operative techniques to perform TKR. Until recently the most common technique is the anterior approach to the knee and then using mechanical instrumentation to make the bone cuts for the femur and tibia. A second popular technique is the anterior approach to the knee and then using a kinematic alignment to make the bone cuts.

The investigators wish to compare short term results of the two operative techniques as evidenced in patient objective functional scores and also by evaluating the gait of the patients by using the REHAGAIT ANALYZER PRO by HASOMED inc. Magdeburg Germany.

Being tested
REHAGAIT ANYLIZER
Keywords
total knee replacement, gait analysis, PROMS, mechanical aligment, kinematic alignment
Medical subject headings
Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REHAGAIT ANYLIZERDiagnostic test

    Gait analysis instrumentation

Study groups in NCT03605290
Study groupRoleWhat they receive
Mechanically aligned TKRActive comparatorpatients were operated using the standard mechanically aligned technique
Receives: Diagnostic Test: REHAGAIT ANYLIZER
Kinematically aligned TKRExperimentalpatients were operated using the newer mechanically aligned technique
Receives: Diagnostic Test: REHAGAIT ANYLIZER

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PROMS

    The patients will fill out functionala and quality of life assessment questionnaires

    Measured: At least 6 months post operatively

  2. Gait analysis

    The patients will perform a gait analysis using the REHAGAIT system.

    Measured: At least 6 months post operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2018
  2. Study start15 Jun 2018
  3. Primary completion1 Jan 2020
  4. Study completion1 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03605290
Sponsor's protocol ID
003418EMC
Status last verified
Feb 2020
First submitted
18 Jun 2018
Last updated
12 Feb 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing REHAGAIT ANYLIZER in people with Gait, Unsteady and Knee Arthropathy, run by HaEmek Medical Center, Israel at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PROMS (time frame: At least 6 months post operatively). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in